Tuesday, 26 May 2020

Biocon Subsidiary Receives Nod To Use Cytosorb In Covid-19 Treatment

The licence will be effective until the COVID-19 outbreak is controlled in the country, the company said in a regulatory filing.

from NDTV News - Special https://ift.tt/2M3KuBA
via
at
Labels:

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)

White House Reviews Candidates To Potentially Replace Steve Feinberg

Senior officials at the White House have been quietly vetting potential replacements for Deputy Secretary of Defense Steve Feinberg.  Reut...